-48.5%
JOBY vs GSK
+31.2%
-79.8%
-66.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.9% | 0.0% | -1.9% |
| 7D | -3.4% | -1.8% | -1.6% | -3.4% |
| 30D | -13.6% | -2.2% | -11.4% | -13.5% |
| 3M | -39.5% | -1.8% | -37.7% | -39.6% |
| 6M | -31.9% | -10.6% | -21.2% | -31.6% |
| YTD | -48.9% | +4.4% | -53.4% | -49.2% |
| 1Y | -48.5% | +30.4% | -79.0% | -48.3% |
| All | -48.5% | +31.2% | -79.8% | -48.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling